Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD.

J Clin Invest. 1996 Sep 1;98(5):1107-13.

PMID:
8787672
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.

Kojima T, Horiuchi T, Nishizaka H, Sawabe T, Higuchi M, Harashima SI, Yoshizawa S, Tsukamoto H, Nagasawa K, Niho Y.

Arthritis Rheum. 2000 Jan;43(1):135-9.

PMID:
10643709
[PubMed - indexed for MEDLINE]
Free Article
3.

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

Del-Rey M, Ruiz-Contreras J, Bosque A, Calleja S, Gomez-Rial J, Roldan E, Morales P, Serrano A, Anel A, Paz-Artal E, Allende LM.

Blood. 2006 Aug 15;108(4):1306-12. Epub 2006 Apr 20.

PMID:
16627752
[PubMed - indexed for MEDLINE]
Free Article
4.

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

Bi LL, Pan G, Atkinson TP, Zheng L, Dale JK, Makris C, Reddy V, McDonald JM, Siegel RM, Puck JM, Lenardo MJ, Straus SE.

BMC Med Genet. 2007 Jul 2;8:41.

PMID:
17605793
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Studies on Fas ligand expression in patients with systemic lupus erythematosus].

Feng Y.

Hokkaido Igaku Zasshi. 1997 Jul;72(4):443-55. Japanese.

PMID:
9266252
[PubMed - indexed for MEDLINE]
6.

Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia.

Nolsøe RL, Kelly JA, Pociot F, Moser KL, Kristiansen OP, Mandrup-Poulsen T, Harley JB.

Genes Immun. 2005 Dec;6(8):699-706.

PMID:
16163374
[PubMed - indexed for MEDLINE]
7.
8.

The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.

Chen JY, Wang CM, Ma CC, Chow YH, Luo SF.

Genes Immun. 2005 Mar;6(2):123-8.

PMID:
15674374
[PubMed - indexed for MEDLINE]
9.

Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.

Arthritis Rheum. 1998 Feb;41(2):344-53. Review.

PMID:
9485093
[PubMed - indexed for MEDLINE]
10.

Complete mutation scan of the human Fas ligand gene: linkage studies in Type I diabetes mellitus families.

Nolsøe RL, Kristiansen OP, Larsen ZM, Johannesen J, Pociot F, Mandrup-Poulsen T.

Diabetologia. 2002 Jan;45(1):134-9.

PMID:
11845233
[PubMed - indexed for MEDLINE]
11.

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S.

Cell. 1994 Mar 25;76(6):969-76.

PMID:
7511063
[PubMed - indexed for MEDLINE]
12.

Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma.

Kim HS, Lee SH, Lee JW, Soung YH, Lee JH, Park JY, Cho YG, Kim CJ, Kim SY, Lee YS, Park WS, Kim SH, Lee JY, Yoo NJ.

APMIS. 2003 Apr;111(4):490-6.

PMID:
12780524
[PubMed - indexed for MEDLINE]
13.

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

Aspinall AI, Pinto A, Auer IA, Bridges P, Luider J, Dimnik L, Patel KD, Jorgenson K, Woodman RC.

Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):227-38.

PMID:
10575548
[PubMed - indexed for MEDLINE]
14.

Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia.

Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M.

Clin Exp Rheumatol. 1999 May-Jun;17(3):339-42.

PMID:
10410268
[PubMed - indexed for MEDLINE]
15.

Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.

Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.

Cell Immunol. 2006 Feb;239(2):121-8. Epub 2006 Jun 30. Erratum in: Cell Immunol. 2006 Oct;243(2):127.

PMID:
16808908
[PubMed - indexed for MEDLINE]
16.
17.

Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients.

Tsuzaka K, Takeuchi T, Onoda N, Pang M, Abe T.

J Autoimmun. 1998 Oct;11(5):381-5.

PMID:
9802920
[PubMed - indexed for MEDLINE]
18.

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.

Arthritis Rheum. 1997 Feb;40(2):306-17.

PMID:
9041943
[PubMed - indexed for MEDLINE]
19.

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Jackson CE, Fischer RE, Hsu AP, Anderson SM, Choi Y, Wang J, Dale JK, Fleisher TA, Middelton LA, Sneller MC, Lenardo MJ, Straus SE, Puck JM.

Am J Hum Genet. 1999 Apr;64(4):1002-14.

PMID:
10090885
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.

Nambiar MP, Enyedy EJ, Warke VG, Krishnan S, Dennis G, Wong HK, Kammer GM, Tsokos GC.

Arthritis Rheum. 2001 Jun;44(6):1336-50.

PMID:
11407693
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk